Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999

Annals of Internal Medicine

Volumn 138, Issue 7, 2003, Pages

  Steinman, Michael A ^a   Gonzales, Ralph ^b   Linder, Jeffrey A ^b   Landefeld, C Seth ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; COMMON COLD; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; ADULT; AMBULATORY CARE; ANTIBIOTIC RESISTANCE; CHILD; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; UNITED STATES;

ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RESPIRATORY TRACT INFECTIONS; UNITED STATES;

EID: 0037387808     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-7-200304010-00008     Document Type: Article

References (63)

1. Resistance of Streptococcus pneumoniae to fluoroquinolones - United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2001;50:800-4. [PMID: 11785571]
2. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;286:1857-62. [PMID: 11597287]
3. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-8. [PMID: 10052444]
4. Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet. 1995;345:665-6. [PMID: 7885119]
5. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234-40. [PMID: 8604178]
6. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA. 1996;275:206-9. [PMID: 8604173]
7. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis. 2001;33 Suppl 3:S206-13. [PMID: 11524720]
8. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441-6. [PMID: 9250845]
9. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A. 1999;96:1152-6. [PMID: 9927709]
10. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343:1925-32. [PMID: 11136263]
11. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-9. [PMID: 7807660]
12. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA. 2001; 286:1181-6. [PMID: 11559262]
13. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med. 2002;162: 41-7. [PMID: 11784218]
14. Piccirillo JF, Mager DE, Frisse ME, Brophy RH, Goggin A. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA. 2001;286:1849-56. [PMID: 11597286]
15. National Center for Health Statistics. Public Use Micro-Data File Documentation, National Ambulatory Medical Care Survey, 1999. Hyattsville, MD: National Technical Information Service; 2001.
16. National Center for Health Statistics. Public Use Data Tape Documentation: 1992 National Ambulatory Medical Care Survey. Hyattsville, MD: U.S. Department of Health and Human Services; 1994.
17. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719-25.
18. International Classification of Diseases, Ninth Revision, Clinical Modification. Los Angeles, CA: Practice Management Information; 1998.
19. Stata Corp. Overview of survey estimation. Stata User's Guide, Release 6. College Station, TX: Stata Pr; 1999:321-33.
20. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med. 2000; 133:128-35. [PMID: 10896639]
21. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med. 2001;134: 506-8. [PMID: 11255529]
22. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med. 2001;134:518-20. [PMID: 11255531]
23. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med. 2001;134:487-9. [PMID: 11255525]
24. Snow V, Mottur-Pilson C, Hickner JM. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med. 2001;134:495-7. [PMID: 11255527]
25. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001;108:239-47. [PMID: 11483783]
26. Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF. Pharyngitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101: 171-4.
27. O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Acute sinusitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:174-7.
28. O'Brien KL, Dowell SF, Schwartz B, Marcy SM, Phillips WR, Gerber MA. Cough illness/bronchitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:178-81.
29. Rosenstein N, Phillips WR, Gerber MA, Marcy SM, Schwartz B, Dowell SF. The common cold-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:181-4.
30. Drug Topics Red Book. 103rd ed. Montvale, NJ: Medical Economics; 1999.
31. Sensakovic JW, Smith LG. Beta-lactamase inhibitor combinations. Med Clin North Am. 1995;79:695-704. [PMID: 7791417]
32. Sable CA, Scheld WM. Fluoroquinolones: how to use (but not overuse) these antibiotics. Geriatrics. 1993;48:41-4, 49-51. [PMID: 8500773]
33. Marshall WF, Blair JE. The cephalosporins. Mayo Clin Proc. 1999;74:187-95. [PMID: 10069359]
34. Wright AJ. The penicillins. Mayo Clin Proc. 1999;74:290-307. [PMID: 10090000]
35. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med. 1999;341:233-9. [PMID: 10413735]
36. Clavo-Sánchez AJ, Girón-González JA, López-Prieto D, Canueto-Quintero J, Sánchez-Porto A, Vergara-Campos A, et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis. 1997;24:1052-9. [PMID: 9195057]
37. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis. 2001;33 Suppl 3:S187-92. [PMID: 11524718]
38. Neu HC. The crisis in antibiotic resistance. Science. 1992;257:1064-73. [PMID: 1509257]
39. Resident Population Estimates of the United States by Age and Sex: April 1, 1990 to July 1, 1999, with Short-Term Projection to November 1, 2000. Accessed at www.census.gov/population/estimates/nation/intfile2-1.txt on 13 November 2001.
40. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33:89-94. [PMID: 11389500]
41. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41-50. [PMID: 11434731]
42. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-82. [PMID: 10987697]
43. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, Lau J. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother. 2001;48:677-89. [PMID: 11679557]
44. Appelbaum PC. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Clin Infect Dis. 2000;31 Suppl 2:S29-34. [PMID: 10984325]
45. Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9. [PMID: 9951971]
46. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24. [PMID: 11136262]
47. Sargent J, Welch HG. Reducing "unnecessary" antibiotic use in primary care: hard rules, soft calls [Editorial]. Eff Clin Pract. 2001;4:136-8. [PMID: 11434077]
48. Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med. 1975;9:111-6. [PMID: 1093256]
49. Bloom BS. Daily regimen and compliance with treatment [Editorial]. BMJ. 2001;323:647. [PMID: 11566816]
50. Walker S, McGeer A, Simor AE, Armstrong-Evans M, Loeb M. Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people? A qualitative study of physicians' and nurses' perceptions. CMAJ. 2000; 163:273-7. [PMID: 10951723]
51. Gonzales R, Barrett PH Jr, Steiner JF. The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections. J Gen Intern Med. 1999;14:151-6. [PMID: 10203620]
52. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996;43:56-62. [PMID: 8691181]
53. Jain A, Ogden J. General practitioners' experiences of patients' complaints: qualitative study. BMJ. 1999;318:1596-9. [PMID: 10364121]
54. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8. [PMID: 7091173]
55. Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-3. [PMID: 2341925]
56. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-7. [PMID: 11347622]
57. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-80. [PMID: 10647801]
58. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994;271:684-9. [PMID: 8309031]
59. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-83. [PMID: 10940134]
60. Bodenheimer T. Uneasy alliance-clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539-44. [PMID: 10816196]
61. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14:651-7. [PMID: 10571712]
62. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 1983;308:1457-63. [PMID: 6406886]
63. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q. 1989; 67:268-317. [PMID: 2698446]